Experimental gene therapy offers hope for babies with rare brain disease

NCT ID NCT04771416

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times

Summary

This study tests a gene therapy called PBKR03 for children under 9 months with early infantile Krabbe disease, a severe genetic disorder affecting the brain and nerves. The therapy aims to deliver a working copy of the GALC gene to help stop or slow the disease. Researchers will check safety and effectiveness by testing different doses in 24 children.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKODYSTROPHY, GLOBOID CELL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Amsterdam UMC

    Amsterdam, Netherlands

  • Ann & Robert Lurie

    Chicago, Illinois, 60611, United States

  • Hospital De Clinicas De Porto Alegre

    Porto Alegre, Brazil

  • Manchester University

    Manchester, United Kingdom

  • Montreal Children's Hospital

    Montreal, Canada

  • New York-Presbyterian

    New York, New York, 10065, United States

  • Shaare Zadek Medical Center

    Jerusalem, Israel

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • University of Utah School of Medicine

    Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.